Neurological Sciences

, Volume 31, Supplement 1, pp 137–139 | Cite as

Non-pharmacological approach to migraine prophylaxis: part II

  • Paola Schiapparelli
  • Gianni Allais
  • Ilaria Castagnoli Gabellari
  • Sara Rolando
  • Maria Grazia Terzi
  • Chiara Benedetto
Future Perspectives

Abstract

Acupuncture has been used to both prevent and treat diseases for over 3,000 years. Recently, a Cochrane review on its use in migraine concluded that acupuncture is effective and should be considered as a prophylactic measure for patients with frequent or insufficiently controlled migraine attacks. In contrast, there is no clear evidence to support or refute the use of homeopathy in the management of migraine. Among vitamins and other supplements, riboflavin and coenzyme Q10 significantly decreased the frequency of migraine attacks. Alpha lipoic acid also reduced migraine frequency, albeit not significantly as compared to placebo. The prophylactic efficacy of magnesium, particularly for children and menstrually related migraine, has recently been substantiated. Among the herbal remedies, butterbur significantly decreases attack frequency, whereas the efficacy of feverfew was not confirmed in a Cochrane review, probably because of the 400% variations in the dosage of its active principle. Finally, ginkgolide B has proved significantly effective in controlling migraine with aura and pediatric migraine in uncontrolled studies that need a confirmation.

Keywords

Acupuncture Complementary therapies Dietary supplements Migraine Phytotherapy 

References

  1. 1.
    Gaul C, Eismann R, Schmidt T, May A, Leinisch E, Wieser T, Evers S, Henkel K, Franz G, Zierz S (2009) Use of complementary and alternative medicine in patients suffering from primary headache disorders. Cephalalgia 29:1069–1078PubMedCrossRefGoogle Scholar
  2. 2.
    Melchart D, Linde K, Fisher P, Berman B, White A, Vickers A, Allais G (2001) Acupuncture for idiopathic headache. Cochrane Database Syst Rev (1):CD001218Google Scholar
  3. 3.
    Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR (2009) Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev (1):CD001218Google Scholar
  4. 4.
    Owen JM, Chom DC, Green BN (2004) Homeopathic treatment of headaches: a systematic review of the literature. J Chiropr Med 3(2):45–52PubMedCrossRefGoogle Scholar
  5. 5.
    Schoenen J, Jacquy J, Lenaerts M (1998) Effectiveness of high-dose riboflavin in migraine prophylaxis—a randomized controlled trial. Neurology 50:466–470PubMedGoogle Scholar
  6. 6.
    Sandor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, Seidel L, Agosti RM, Schoenen J (2005) Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 64:713–715PubMedGoogle Scholar
  7. 7.
    Hershey AD, Powers SW, Vockell AL, Lecates SL, Ellinor PL, Segers A, Burdine D, Manning P, Kabbouche MA (2007) Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 47(1):73–80PubMedCrossRefGoogle Scholar
  8. 8.
    Magis D, Ambrosini A, Sándor P, Jacquy J, Laloux P, Schoenen J (2007) A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis. Headache 47:52–57PubMedCrossRefGoogle Scholar
  9. 9.
    Grazzi L, Andrasik F, Usai S, Bussone G (2007) Magnesium as a preventive treatment for paediatric episodic tension-type headache: results at 1-year follow-up. Neurol Sci 28(3):148–150PubMedCrossRefGoogle Scholar
  10. 10.
    Sun-Edelstein C, Mauskop A (2009) Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother 9(3):369–379PubMedCrossRefGoogle Scholar
  11. 11.
    Agosti R, Duke RK, Chrubasik JE, Cheubasik S (2006) Effectiveness of Petasites hybridus preparations in the prophylaxis of migraine: a systematic review. Phytomedicine 13:743–746PubMedCrossRefGoogle Scholar
  12. 12.
    Kaufeler R, Polasek W, Brattstrom A, Koetter U (2006) Efficacy and safety of butterbur herbal extract Ze 339 in seasonal allergic rhinitis: postmarketing surveillance study. Adv Ther 23:373–384PubMedCrossRefGoogle Scholar
  13. 13.
    Pittler MH, Ernst E (2004) Feverfew for preventing migraine. Cochrane Database Syst Rev (1):CD002286Google Scholar
  14. 14.
    Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH (2005) Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention—a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia 25:1031–1041PubMedCrossRefGoogle Scholar
  15. 15.
    D’Andrea G, Bussone G, Allais G, Aguggia M, D’Onofrio F, Maggio M, Moschiano F, Saracco MG, Terzi MG, Petretta V, Benedetto C (2009) Efficacy of Ginkgolide B in the prophylaxis of migraine with aura. Neurol Sci 30(Suppl 1):S121–S124PubMedCrossRefGoogle Scholar
  16. 16.
    Usai S, Grazzi L, Andrasik F, Bussone G (2010) An innovative approach for migraine prevention in young age: a preliminary study. Neurol Sci 31(Suppl 1). doi:10.1007/s10072-010-0321-6

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Paola Schiapparelli
    • 1
  • Gianni Allais
    • 1
  • Ilaria Castagnoli Gabellari
    • 1
  • Sara Rolando
    • 1
  • Maria Grazia Terzi
    • 1
  • Chiara Benedetto
    • 1
  1. 1.Department of Gynecology and ObstetricsWomen’s Headache Center, University of TurinTurinItaly

Personalised recommendations